Janus Henderson Investors US’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$131M Buy
1,963,955
+1,958,263
+34,404% +$130M 0.11% 241
2016
Q4
$371K Hold
5,692
﹤0.01% 1131
2016
Q3
$403K Hold
5,692
﹤0.01% 1139
2016
Q2
$421K Buy
5,692
+782
+16% +$54K ﹤0.01% 1112
2016
Q1
$319K Sell
4,910
-23
-0.5% -$1.56K ﹤0.01% 1104
2015
Q4
$381K Buy
4,933
+23
+0.5% +$1.83K ﹤0.01% 1112
2015
Q3
$404K Sell
4,910
-109,800
-96% -$9.77M ﹤0.01% 1101
2015
Q2
$10.1M Buy
114,710
+46,762
+69% +$4.29M 0.01% 704
2015
Q1
$6M Buy
67,948
+51,022
+301% +$4.53M ﹤0.01% 768
2014
Q4
$1.41M Buy
+16,926
New +$1.4M ﹤0.01% 944

Other funds holding NVS

Janus Henderson Investors US's NVS Position: Q1 2017 in Review

Janus Henderson Investors US increased its Novartis (NVS) stake by 34,404% in Q1 2017, buying an estimated $130M and bringing the position to 1,963,955 shares worth $131M. The position accounts for 0.11% of the portfolio, ranked #241.

Janus Henderson Investors US first reported a position in NVS in Q4 2014 and has held it in 10 quarters since. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Janus Henderson Investors US held 1,963,955 shares of Novartis worth $131M as of Q1 2017.
  • Janus Henderson Investors US bought 1,958,263 Novartis shares in Q1 2017, an estimated $130M.
  • Novartis made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #241 holding.
  • Janus Henderson Investors US first reported a position in Novartis in Q4 2014 and has held it in 10 quarters since.
  • 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.